A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

BACKGROUND: Human hepatocellular carcinoma (HCC) cells are largely deficient of argininosuccinate synthetase and thus auxotrophic for arginine. This study aims to investigate the efficacy and pharmacodynamics of pegylated arginine deiminase (ADI-PEG 20), a systemic arginine deprivation agent, in Asi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yang, T-S, Lu, S-N, Chao, Y, Sheen, I-S, Lin, C-C, Wang, T-E, Chen, S-C, Wang, J-H, Liao, L-Y, Thomson, J A, Wang-Peng, J, Chen, P-J, Chen, L-T
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2010
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2965867/
https://ncbi.nlm.nih.gov/pubmed/20808309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados